Pulmonary tuberculosis in young Korean soldiers: Incidence, drug resistance and treatment outcomes

International Journal of Tuberculosis and Lung Disease

Volumn 10, Issue 9, 2006, Pages 970-974

  Kang, C I ^a   Choi, Chang Min ^a,e   Kim, D H ^a   Kim, C H ^b   Lee, D J ^c   Kim, H B ^d   Kim, N J ^d   Oh, M D ^d   Choe, K W ^d  

^a Armed Forces Yangju Hospital   (South Korea)

^b Ministry of National Defense   (South Korea)

^c Armed Forces Medical Command ^*  (South Korea)

^d Seoul National University College of Medicine   (South Korea)

^e The Armed Forces Capital Hospital   (South Korea)

Author keywords

Incidence; Military personnel; Treatment outcome; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; HUMAN; INCIDENCE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MEDICAL RECORD; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PUBLIC HOSPITAL; SOLDIER; SOUTH KOREA; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; DRUG RESISTANCE; HUMANS; INCIDENCE; KOREA; MALE; MILITARY PERSONNEL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 33748583462     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. World Health Organization. Tuberculosis. Geneva, Switzerland: WHO. http://www.who.int/tb Accessed December 2005.
2. Seung K J, Bai G H, Kim S J, Lew W J, Park S K, Kim J Y. The treatment of tuberculosis in South Korea. Int J Tuberc Lung Dis 2003; 7: 912-919.
3. Hong Y P, Kim S J, Lew W J, Lee E K, Han Y C. The seventh nationwide tuberculosis prevalence survey in Korea, 1995. Int J Tuberc Lung Dis 1998; 2: 27-36.
4. Smith B, Ryan M A, Gray G C, Polonskyc J M, Trumpd D H. Tuberculosis infection among young adults enlisting in the United States Navy. Int J Epidemiol 2002; 31: 934-939.
5. Ciftci F, Tozkoparan E, Deniz O, Bozkanat E, Kibaroglu E, Demirci N. The incidence of tuberculosis in the armed forces: a good reflection of the whole population. Int J Tuberc Lung Dis 2004; 8: 965-968.
6. Dupon M, Texier-Maugein J, Leroy V. Tuberculosis and HIV infection: a cohort study of incidence and susceptibility to antituberculous drugs, Bordeaux, 1985-1993. AIDS 1995; 9: 577-583.
7. Haddad M B, Wilson T W, Ijaz K, Marks S M, Moore M. Tuberculosis and homelessness in the United States, 1994-2003. JAMA. 2005; 293: 2762-2766.
8. Jasmer R M, Seaman C B, Gonzalez L C, Kawamura L M, Osmond D H, Daley C L. Tuberculosis treatment outcomes. Directly observed therapy compared with self-administered therapy. Am J Respir Crit Care Med 2004; 170: 561-566.
9. Korean National Institute of Health. Communicable Disease Information System. Seoul, Korea: Korean National Institute of Health, http://dis.cdc.go.kr/ english/index.htm Accessed December 2005.
10. Bai G H, Kim S J, Lew W J. Incidence of pulmonary tuberculosis in Korean civil servants: second study, 1992-1994. Int J Tuberc Lung Dis 2001; 5: 346-353.
11. Zellweger J P, Coulon P. Outcome of patients treated for tuberculosis in Vaud country, Switzerland. Int J Tuberc Lung Dis 1998; 2: 372-377.